Sign Up Today and Learn More About Blackrock Neurotech Stock
Invest in or calculate the value of your shares in Blackrock Neurotech or other pre-IPO companies through EquityZen's platform.
Blackrock Neurotech Stock
Blackrock Neurotech is the platform for brain-computer interface (BCI) technology and manufacturing.
About Blackrock Neurotech Stock
Founded
2008
Headquarters
Salt Lake City, UT, US
Industries
Software, Artificial Intelligence, Data and Analytics
Blackrock Neurotech’s mission is to provide innovative tools and neurotech expertise to translate technology into a novel, implantable clinical solutions that improve human lives.
Blackrock Neurotech Press Mentions
Stay in the know about the latest news on Blackrock Neurotech
The Week’s 10 Biggest Funding Rounds: CoreWeave’s $1.1B Raise Leads Huge Week
news • May 03, 2024
The 10 Biggest Rounds Of April: Xaira And Pine Gate Lead Huge Month Of Megadeals
news • May 02, 2024
What $200 Million In Crypto Cash Means For Blackrock Neurotech
forbes • Apr 30, 2024
Crypto company Tether invests $200 million in brain-chip maker Blackrock Neurotech
kdal610 • Apr 29, 2024
Tether’s Diversification Campaign Begins to Take Shape with $200M Investment in Biotech Startup
nftgators • Apr 29, 2024
Blackrock Neurotech Management
Leadership team at Blackrock Neurotech
Board Member
Jan Hardorp
CFO
Peter Donato
Join now and verify your accreditation status to gain access to:
- Blackrock Neurotech current valuation
- Blackrock Neurotech stock price
- Available deals in Blackrock Neurotech and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Blackrock Neurotech stock?
Accredited investors can buy pre-IPO stock in companies like Blackrock Neurotech through EquityZen funds. These investments are made available by existing Blackrock Neurotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Blackrock Neurotech stock?
Shareholders can sell their Blackrock Neurotech stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."